Nikomorfiin

Nicomorphine is a semi-synthetic opioid agonist of the morphine family, classified as both an opioid and a depressant. It is estimated to be two to three times more potent than morphine and is characterized by a notably rapid onset of effects, attributed to its increased lipid solubility. Nicomorphine sees limited medical use in a small number of countries. As with other opioids, it carries significant habit-forming potential.

Classification

Chemical: Medicine
Chemical: Morphinan
Chemical: Opioid
Psychoactive: Depressant
Tag: Habit-Forming
Tag: Tentative

Effects

Respiratory Depression
Itchiness
Nausea
Sedation
Motor Impairment
Constipation
Reduced Anxiety
Euphoria
Anxiety Suppression
Cognitive Euphoria
Sadness
Mood Lift
Dulled Perception
Decreased Libido
Increased Music Appreciation
Internal Hallucination
Cognitive Dysphoria
Sound Amplification

Routes of Administration

Oral

Dosage

Heavy: 20 mg
Light: 2.5 – 5 mg
Common: 5 – 10 mg
Strong: 10 – 20 mg
Threshold: 2.5 mg

Duration

After Effects: 1-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu